Novo CEO pressed by Senate to cut selling prices of weight problems, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the company would consider new talks with insurers with regards to the checklist prices of Wegovy and copyright should they pledge to keep the medicines on their own formularies. https://marioskaqg.blogcudinti.com/30665864/everything-about-healthcare-news